Dividend26 May 2026, 10:11 pm
Venus Remedies: Final Dividend of ₹10/Share Approved
AI Summary
Venus Remedies Ltd announced the approval of a final dividend of ₹10 per equity share (100% on face value of ₹10 each) subject to shareholder approval at the 37th Annual General Meeting (AGM) scheduled for August 20, 2026, via video conferencing. The record date for determining dividend eligibility is August 7, 2026, with payment within 30 days of AGM approval, subject to tax deduction. The company also appointed M/s C. L Bansal & Associates as Cost Auditors and M/s Mehra Goel & Co as Internal Auditors for FY 2026-27. Trading window closed from April 1, 2026.
Key Highlights
- Final dividend of ₹10 per share (100%) approved, pending shareholder approval at AGM.
- Record date for dividend eligibility is set for August 7, 2026.
- 37th Annual General Meeting scheduled for August 20, 2026, via video conferencing.
- M/s C. L Bansal & Associates appointed as Cost Auditors for FY 2026-27.
- M/s Mehra Goel & Co appointed as Internal Auditors for FY 2026-27.
Price Impact
More from VENUSREM